Capstone Investment Advisors
RXST icon

Capstone Investment Advisors’s RxSight RXST Stock Holding History

Capstone Investment Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-127,200
Closed -$6.56M – 2413
2024
Q1 		$6.56M Buy
127,200
+111,269
+698% +$5.46M 0.02% 359
2023
Q4 		$642K Buy
+15,931
New +$467K ﹤0.01% 1219

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Capstone Investment Advisors's RXST Position: Q2 2024 in Review

Capstone Investment Advisors sold out of RxSight (RXST) in Q2 2024, closing a stake of 127,200 shares — an estimated $6.56M sold.

Capstone Investment Advisors first reported a position in RXST in Q4 2023 and held it in 2 quarters. The position peaked at $6.56M in Q1 2024. 228 funds tracked by Wall St. Rank hold RXST as of Q2 2024.

  • Capstone Investment Advisors reported no remaining RxSight position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 127,200 RxSight shares in Q2 2024, an estimated $6.56M.
  • Capstone Investment Advisors first reported a position in RxSight in Q4 2023 and held it in 2 quarters.
  • Capstone Investment Advisors's RxSight position peaked at $6.56M in Q1 2024.
  • 228 funds tracked by Wall St. Rank held RxSight as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.